查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529799

Leucafferesis 市场规模、份额和趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2024-2030 年

Leukapheresis Market Size, Share & Trends Analysis Report By Product (Leukapheresis Devices, Leukapheresis Disposables), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

白血球去除术市场规模与趋势

预计2023年全球白血球清除市场规模为1.918亿美元，预估2024年至2030年复合年增长率为10.94%。血液学和自体免疫疾病的盛行率不断上升、白血球清除技术的进步以及对个人化医疗的需求不断增长预计将推动市场成长。此外，增加对研发活动的投资也进一步促进了市场的成长。

白血病、淋巴瘤等血液疾病以及类风湿性关节炎和多发性硬化症等自体免疫疾病的盛行率不断上升，大大推动了市场的成长。例如，白血病和淋巴瘤协会报告称，预计 2023 年美国将总合184,720 人被诊断出患有白血病、淋巴瘤或骨髓瘤。同样，2023 年 5 月，《柳叶刀》对 2,200 万人进行的一项研究发现，十分之一的人患有自体免疫疾病，其中十分之一受到社会经济、季节和地理因素的影响，它强调了各种因素的影响，并提供了对原因的类风湿性关节炎了解。因此，在预测期内推动了白血球分离术的需求。

白血球分离技术的进步正在提高手术的效率、安全性和结果。自动化系统、连续流离心系统和封闭式系统设备的采用有望提高白血球分离术的准确性和有效性。它减少了手术时间，最大限度地减少了捐赠者的不适，并优化了细胞收集产量。 2022 年 10 月，美国单采协会 (ASFA) 临床应用委员会与 IEC 治疗小组委员会、AABB 和其他各种组织共同製作了一份白皮书。本文件概述了进行白血球分离术以从儿科和成人患者身上采集单核细胞作为免疫效应细胞治疗的一部分的指南，无论是在商业性活动还是研究倡议中。因此，预计将在预测期内推动市场成长。

将治疗策略与个别患者情况相匹配的个人化医疗方法的转变正在推动对白血球分离术的需求。白血球清洗在嵌合体抗原受体 (CAR) T 细胞疗法和干细胞移植等细胞疗法中发挥重要作用。 2023 年 12 月，发表在《Transfusion and Apheresis Science》杂誌上的一篇论文强调了 CAR-T 细胞生产的挑战，首先是从週边血液中收集白血球。报导强调了有效的白血球分离产品在成功的 CAR-T 细胞治疗中所发挥的重要作用，并强调了了解影响 T 细胞品质的因素的重要性。

全球白血球分离术市场报告细分

该报告预测了全球、区域和国家层面的收益成长，并对 2018 年至 2030 年各子区隔的最新行业趋势进行了分析。在这项研究中，Grand View Research, Inc. 根据产品、应用、最终用途和地区对全球白血球减少症市场报告进行了细分。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章白血球去除术市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/补充市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 白血球去除术市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章白血球分离市场：依产品估计和趋势分析

  • 产品细分仪表板
  • 全球白血球市场产品波动分析
  • 2018-2030年全球白血球清除剂市场规模与趋势分析（依产品）
  • 白血球去除装置
  • 用于白血球清除的一次性产品

第五章白血球去除术市场：按应用、估计和趋势分析

  • 使用细分仪表板
  • 全球白血球分离术市场应用变迁分析
  • 2018-2030 年全球白血球分离术市场规模与趋势分析（按应用）
  • 研究用途
  • 治疗用途

第六章 白血球分离术市场：依最终用途分类的估计与趋势分析

  • 最终用途细分仪表板
  • 全球白血球分离术市场的最终用途变化分析
  • 2018-2030 年全球白血球清除剂市场规模与趋势分析（依最终用途）
  • 血液中心
  • 学术研究所
  • 製药和生物技术公司
  • 医院/诊所

第七章白血球去除术市场：按产品、应用和最终用途进行的区域估计和趋势分析

  • 2023 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • Charles River Laboratories International, Inc.
    • Adacyte Therapeutics
    • AllCells, LLC
    • Asahi Kasei Medical
    • Haemonetics Corporation
    • Macopharma
    • Cerus Corporation
    • SB-Kawasumi Laboratories, Inc.
    • StemExpress, LLC.
    • Lonza Group AG
Product Code: GVR-4-68040-357-9

Leukapheresis Market Size & Trends

The global leukapheresis market size was estimated at USD 191.8 million in 2023 and is projected to grow at a CAGR of 10.94% from 2024 to 2030. The increasing prevalence of blood disorders and autoimmune diseases, technological advancements in leukapheresis procedures and growing demand for personalized medicine are expected to drive the market growth. Moreover, the increasing investments in research and development activities is further contributing to the market growth.

The rising incidence of blood disorders like leukemia, lymphoma, and autoimmune diseases such as rheumatoid arthritis and multiple sclerosis are significantly driving the market growth. For instance, the Leukemia & Lymphoma Society reports that an estimated total of 184,720 people in the U.S. are expected to receive a diagnosis of leukemia, lymphoma, or myeloma in 2023. Similarly, in May 2023, a study in The Lancet involving 22 million people finds autoimmune disorders affect 1 in 10 individuals, highlighting the influence of socioeconomic, seasonal, and regional factors, and offers insights into the causes of these diseases including Rheumatoid arthritis, Type 1 diabetes, and Multiple sclerosis. Thus, propelling the demand for leukapheresis over the forecast period.

The advancements in leukapheresis technologies are improving the efficiency, safety, and outcomes of the procedure. The introduction of automated systems, continuous flow centrifugation systems, and closed-system devices is expected to enhance the precision and effectiveness of leukapheresis. Thereby reducing the procedure times, minimize donor discomfort, and optimize cell collection yields. In October 2022, the Clinical Applications Committee of The American Society for Apheresis (ASFA), along with the IEC Therapy Subcommittee, AABB, and various other organizations, prepared a white paper. This document outlines guidelines for performing leukapheresis to retrieve mononuclear cells from pediatric and adult patients who are part of immune effector cell therapies, whether for commercial endeavors or research initiatives. Thus, anticipated to propel the market growth over the forecast period.

The shift towards personalized medicine approaches that tailor treatment strategies to individual patient profiles are fueling the demand for leukapheresis procedures. Leukapheresis plays a crucial role in cell-based therapies, such as chimeric antigen receptor (CAR) T-cell therapy and stem cell transplantation. In December 2023, an article in Transfusion and Apheresis Science underscored the challenges in manufacturing CAR-T cells, beginning with the extraction of T cells through leukapheresis from peripheral blood. The article emphasized the critical role of an effective leukapheresis product in achieving successful CAR-T cell therapy and highlighted the significance of comprehending the factors that impact T cell quality.

Global Leukapheresis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global leukapheresis market report based on product, application, end-use, and region.

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Leukapheresis Devices

Centrifugal Devices

Membrane Separators

  • Leukapheresis Disposables
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Research Application

Cancer Research

Immunology Research

Others

  • Therapeutics Application

Hematologic Disorders

Autoimmune Diseases

Others

  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Blood Centers
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Leukapheresis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. The increasing prevalence of blood disorders and autoimmune diseases
      • 3.2.1.2. Technological advancements in leukapheresis procedures
      • 3.2.1.3. Growing demand for personalized medicine
      • 3.2.1.4. Rising investments in research& development
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High equipment costs
  • 3.3. Leukapheresis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Leukapheresis Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Leukapheresis Market Product Movement Analysis
  • 4.3. Global Leukapheresis Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Leukapheresis Devices
    • 4.4.1. Leukapheresis devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Centrifugal Devices
      • 4.4.2.1. Centrifugal Devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Membrane Separators
      • 4.4.3.1. Membrane separators market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Leukapheresis Disposables
    • 4.5.1. Leukapheresis disposables market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Leukapheresis Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Leukapheresis Market Application Movement Analysis
  • 5.3. Global Leukapheresis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Research Application
    • 5.4.1. Research application market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Cancer Research
      • 5.4.2.1. Cancer research market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Immunology Research
      • 5.4.3.1. Immunology research market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Therapeutics Application
    • 5.5.1. Therapeutics application market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.2. Hematologic Disorders
      • 5.5.2.1. Hematologic disorders market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.3. I Autoimmune Diseases
      • 5.5.3.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Leukapheresis Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Segment Dashboard
  • 6.2. Global Leukapheresis Market End-use Movement Analysis
  • 6.3. Global Leukapheresis Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Blood Centers
    • 6.4.1. Blood centers institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Pharmaceutical & Biotechnology Companies
    • 6.6.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Hospitals & Clinics
    • 6.7.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Leukapheresis Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive scenario
      • 7.5.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive scenario
      • 7.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Charles River Laboratories International, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Adacyte Therapeutics
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. AllCells, LLC
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Asahi Kasei Medical
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Haemonetics Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Macopharma
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Cerus Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. SB-Kawasumi Laboratories, Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. StemExpress, LLC.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Lonza Group AG
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviation
  • Table 2. Global leukapheresis market, by region, 2018 - 2030 (USD Million)
  • Table 3. Global leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 4. Global leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 5. Global leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 6. North America leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 8. North America leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 9. North America leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 10. U.S. leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 11. U.S. leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 12. U.S. leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 13. Canada leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 14. Canada leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 15. Canada leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 16. Mexico leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 17. Mexico leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 18. Mexico leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 19. Europe leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 20. Europe leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 21. Europe leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 22. Europe leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 23. Germany leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 24. Germany leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 25. Germany leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 26. UK leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 27. UK leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 28. UK leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 29. France leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 30. France leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 31. France leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 32. Italy leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 33. Italy leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 34. Italy leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 35. Spain leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 36. Spain leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 37. Spain leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 38. Denmark leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 39. Denmark leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 40. Denmark leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 41. Sweden leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 42. Sweden leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 43. Sweden leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 44. Norway leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 45. Norway leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 46. Norway leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 51. China leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 52. China leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 53. China leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 54. Japan leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 55. Japan leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 56. Japan leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 57. India leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 58. India leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 59. India leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 60. South Korea leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 61. South Korea leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 62. South Korea leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 63. Australia leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 64. Australia leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 65. Australia leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 66. Thailand leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 67. Thailand leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 68. Thailand leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 69. Latin America leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 70. Latin America leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 71. Latin America leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 72. Latin America leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 73. Brazil leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 74. Brazil leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 75. Brazil leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 76. Argentina leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 77. Argentina leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 78. Argentina leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 79. MEA leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 80. MEA leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 81. MEA leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 82. MEA leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 83. South Africa leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 84. South Africa leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 85. South Africa leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 86. Saudi Arabia leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 89. UAE leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 90. UAE leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 91. UAE leukapheresis market, by end-use, 2018 - 2030 (USD Million)
  • Table 92. Kuwait leukapheresis market, by product, 2018 - 2030 (USD Million)
  • Table 93. Kuwait leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 94. Kuwait leukapheresis market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Leukapheresis market: Market outlook
  • Fig. 5 Leukapheresis market: Segment outlook
  • Fig. 6 Leukapheresis market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Leukapheresis market driver impact
  • Fig. 9 Leukapheresis market restraint impact
  • Fig. 10 Leukapheresis market: Product outlook and key takeaways
  • Fig. 11 Leukapheresis market: Product movement analysis
  • Fig. 12 Leukapheresis devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Centrifugal devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Membrane separators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Leukapheresis disposables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Leukapheresis market: Application outlook and key takeaways
  • Fig. 17 Leukapheresis market: Application movement analysis
  • Fig. 18 Research application market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Immunology research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Therapeutics application market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 23 Hematologic disorders market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 24 Autoimmune diseases market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 26 Leukapheresis market: End-use outlook and key takeaways
  • Fig. 27 Leukapheresis market: End-use movement analysis
  • Fig. 28 Blood centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global leukapheresis market: Regional outlook and key takeaways
  • Fig. 33 Global leukapheresis market: Regional movement analysis
  • Fig. 34 North America leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Italy leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Spain leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Norway leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Australia leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55. Brazil leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)